Thymoglobulin Versus Basiliximab Induction Therapy for Simultaneous Kidney-Pancreas Transplantation: Impact on Rejection, Graft Function, and Long-Term Outcome - Concepedia

Concepedia

Publication | Closed Access

Thymoglobulin Versus Basiliximab Induction Therapy for Simultaneous Kidney-Pancreas Transplantation: Impact on Rejection, Graft Function, and Long-Term Outcome

44

Citations

14

References

2011

Year

Fateh Bazerbachi, Markus Selzner, Markus Boehnert, Max Marquez, Andrea Norgate, Ian D. McGilvray, Jeffrey Schiff, Mark S. Cattral

Transplantation

Abstract

ATG versus basiliximab induction therapy results in decreased acute cellular rejection in the first year after SPK with similar side effects. Long-term graft function and survival are not affected by induction regimen.

References

	Year	Citations

Page 1